Save the date: Uncover best practices and new insights in chemical safety decision-making with Lhasa
Coming to Argentina on 13 March 2026!
Lhasa Limited is pleased to announce that we will host a symposium in Buenos Aires, Argentina in March 2026.
For our first trip to South America for a co-hosted event with our subsidiary, Consult Lhasa, we have tailored the agenda to address regional regulatory expectations while aligning with international best practices for chemical safety assessments.
Together with D’Amico Sistemas, we’ll equip attendees with the latest knowledge and developments in pharmaceutical science, in silico and analytical methodologies, and regulatory compliance.
The symposium offers the opportunity to collaborate, discuss, and explore key topics in in silico and pharmaceutical science. Key topics include impurity degradation, managing nitrosamine and genotoxicity impurities, risk assessment fundamentals and confident regulatory-aligned control.
Lhasa will engage industry experts and researchers from across the predictive science and regulatory landscape to explore topics that advance confident and expert-led chemical safety decision making.
Event Details
Date: Friday 13th March 2026
Location: Palais Rouge, Palermo, C1177ADA Buenos Aires, Argentina
Meeting Agenda:
-
Session 1 – Smart stability: strategies for compatibility and degradation
Diego Zulkiewicz Gomes, Global Alliances Manager at Lhasa Limited, will explore the compatibility of in silico prediction in stability, specifically degradation pathways.
Expert Rodolfo Rubio García will also showcase expertise in active/excipient compatibility before we delve into case studies from Fernando Alonso, at Gador, and Mariana Mendez, at Baliarda.
-
Session 2 – Managing toxicity risks of impurities in theory and practice
Maria Celeste Del Fueyo and Lucia Toscano, Application Scientists at Lhasa Limited, will discuss the complete theoretical workflow of mutagenicity risk assessments in line with ICH M7 guidelines before delving into a working case study on API impurity classification.
-
Session 3 – Nitrosamines: predictive science and regulatory control
Maria Celeste Del Fueyo will also bring insight into the fundamentals of nitrosamine risk management strategies. Experts on nitrosamine risk assessments in practice, Spektra Consultoria (a Consult Lhasa subsidiary), will explore conservative risk calculations in assessment practice.
Gabriela Silveira, Lead Scientific Consultant at Consult Lhasa provides insight into acceptable intakes and surrogate selection for nitrosamines.
Oscar Cortes from Waters will also discuss applications of mass spectrometry to identify nitrosamines.
-
Session 4 – Trends and challenges in the regulatory landscape across Latin America
Key regulatory authorities and industry experts will delve into emerging topics in pharmaceutical regulations. We’ll touch on cross-contamination control, challenges and opportunities in regulations, ensuring compliance with referencing standards, extractables and leachables, and more. Further details to come!